☰

Stewart Alan Factor - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Movement Disorders
Tree Info Grants Similar researchers PubMed Report error

112/335 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Gong NJ, Clifford GD, Esper CD, Factor SA, McKay JL, Kwon H. Classifying Tremor Dominant and Postural Instability and Gait Difficulty Subtypes of Parkinson's Disease from Full-Body Kinematics. Sensors (Basel, Switzerland). 23. PMID 37837160 DOI: 10.3390/s23198330  0.334
2023 Virmani T, Landes RD, Pillai L, Glover A, Larson-Prior L, Prior F, Factor SA. Gait Declines Differentially in, and Improves Prediction of, People with Parkinson's Disease Converting to a Freezing of Gait Phenotype. Journal of Parkinson's Disease. PMID 37522218 DOI: 10.3233/JPD-230020  0.339
2023 Huddleston DE, Chen X, Hwang K, Langley J, Tripathi R, Tucker K, McKay JL, Hu X, Factor SA. Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson's disease with freezing of gait. Medrxiv : the Preprint Server For Health Sciences. PMID 37461735 DOI: 10.1101/2023.07.04.23292227  0.322
2023 McKay JL, Nye J, Goldstein FC, Sommerfeld B, Smith Y, Weinshenker D, Factor SA. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease. Neurobiology of Disease. 179: 106048. PMID 36813207 DOI: 10.1016/j.nbd.2023.106048  0.354
2022 Bliwise DL, Karroum EG, Greer SA, Factor SA, Trotti LM. Restless Legs Symptoms and Periodic Leg Movements in Sleep Among Patients with Parkinson's Disease. Journal of Parkinson's Disease. PMID 35311713 DOI: 10.3233/JPD-213100  0.376
2021 Bohnen NI, Costa RM, Dauer WT, Factor SA, Giladi N, Hallett M, Lewis SJG, Nieuwboer A, Nutt JG, Takakusaki K, Kang UJ, Przedborski S, Papa SM. Discussion of Research Priorities for Gait Disorders in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34939221 DOI: 10.1002/mds.28883  0.307
2020 Caughman CY, Factor S. A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson's disease 'OFF' episodes. Expert Review of Neurotherapeutics. 21: 169-177. PMID 33227223 DOI: 10.1080/14737175.2020.1855145  0.386
2020 Perez Parra S, McKay JL, Factor SA. Diphasic Worsening of Freezing of Gait in Parkinson's Disease. Movement Disorders Clinical Practice. 7: 325-328. PMID 32258233 DOI: 10.1002/mdc3.12918  0.312
2020 Wallace DM, Wohlgemuth WK, Trotti LM, Amara AW, Malaty IA, Factor SA, Nallu S, Wittine L, Hauser RA. Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review. Movement Disorders Clinical Practice. 7: 250-266. PMID 32258222 DOI: 10.1002/mdc3.12899  0.34
2019 Olanow CW, Factor SA, Espay AJ, Hauser RA, Shill HA, Isaacson S, Pahwa R, Leinonen M, Bhargava P, Sciarappa K, Navia B, Blum D. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. The Lancet. Neurology. PMID 31818699 DOI: 10.1016/S1474-4422(19)30396-5  0.345
2019 Lucas McKay J, Goldstein FC, Sommerfeld B, Bernhard D, Perez Parra S, Factor SA. Freezing of Gait can persist after an acute levodopa challenge in Parkinson's disease. Npj Parkinson's Disease. 5: 25. PMID 31799377 DOI: 10.1038/s41531-019-0099-z  0.341
2019 McKay JL, Hackney ME, Factor SA, Ting LH. Lower Limb Rigidity Is Associated with Frequent Falls in Parkinson's Disease. Movement Disorders Clinical Practice. 6: 446-451. PMID 31392245 DOI: 10.1002/Mdc3.12784  0.338
2019 Factor SA. Parkinson's Disease: Motor Fluctuations. Current Treatment Options in Neurology. 1: 21-32. PMID 11096692 DOI: 10.1007/S11940-999-0029-1  0.447
2017 Vaughan CP, Prizer LP, Vandenberg AE, Goldstein FC, Trotti LM, Hermida AP, Factor SA. A Comprehensive Approach to Care in Parkinson's Disease Adds Quality to the Current Gold Standard. Movement Disorders Clinical Practice. 4: 743-749. PMID 30363392 DOI: 10.1002/mdc3.12508  0.329
2017 Factor SA, Scullin MK, Freeman A, Bliwise DL, McDonald WM, Goldstein FC. Affective Correlates of Psychosis in Parkinson's Disease. Movement Disorders Clinical Practice. 4: 225-230. PMID 28944257 DOI: 10.1002/Mdc3.12381  0.38
2017 Factor SA, McDonald WM, Goldstein FC. The role of neurotransmitters in the development of Parkinson's disease-related psychosis. European Journal of Neurology. PMID 28758318 DOI: 10.1111/ene.13376  0.325
2017 Fox SH, Metman LV, Nutt JG, Brodsky M, Factor SA, Lang AE, Pope LE, Knowles N, Siffert J. Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28370447 DOI: 10.1002/Mds.26976  0.352
2017 Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28195358 DOI: 10.1002/Mds.26942  0.367
2016 Hermida AP, Janjua AU, Glass OM, Vaughan CP, Goldstein F, Trotti LM, Factor SA. A case of lithium-induced parkinsonism presenting with typical motor symptoms of Parkinson's disease in a bipolar patient. International Psychogeriatrics / Ipa. 1-4. PMID 27517671 DOI: 10.1017/S1041610216001101  0.364
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Factor S, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.504
2014 Factor SA, Scullin MK, Sollinger AB, Land JO, Wood-Siverio C, Zanders L, Freeman A, Bliwise DL, Goldstein FC. Freezing of gait subtypes have different cognitive correlates in Parkinson's disease. Parkinsonism & Related Disorders. 20: 1359-64. PMID 25446341 DOI: 10.1016/J.Parkreldis.2014.09.023  0.333
2014 Hauser RA, Isaacson S, Clinch T, Ellenbogen A, Silver D, Struck L, Gil R, Pappert E, Jankovic J, Goldstein S, LeWitt P, Hull K, Thomas M, Danisi F, Factor S, et al. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection Parkinsonism and Related Disorders. 20: 1171-1176. PMID 25239603 DOI: 10.1016/j.parkreldis.2014.08.010  0.338
2014 Moonen AJ, Wijers A, Leentjens AF, Christine CW, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano Ramos C, Shulman L, Singer C, Slevin J, et al. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism & Related Disorders. 20: 644-6. PMID 24679737 DOI: 10.1016/j.parkreldis.2014.02.025  0.311
2013 Silver M, Factor SA. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Parkinsonism & Related Disorders. 19: 758-60. PMID 23632325 DOI: 10.1016/j.parkreldis.2013.03.016  0.335
2012 Revuelta GJ, Uthayathas S, Wahlquist AE, Factor SA, Papa SM. Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment. Experimental Neurology. 237: 464-9. PMID 22967858 DOI: 10.1016/j.expneurol.2012.07.021  0.326
2012 Bliwise DL, Trotti LM, Wilson AG, Greer SA, Wood-Siverio C, Juncos JJ, Factor SA, Freeman A, Rye DB. Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1118-24. PMID 22753297 DOI: 10.1002/Mds.25082  0.309
2012 Smith Y, Wichmann T, Factor SA, DeLong MR. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 213-46. PMID 21956442 DOI: 10.1038/npp.2011.212  0.363
2011 Robottom BJ, Factor SA, Weiner WJ. Movement disorders emergencies Part 2: hyperkinetic disorders. Archives of Neurology. 68: 719-24. PMID 21670395 DOI: 10.1001/archneurol.2011.117  0.433
2011 Robottom BJ, Weiner WJ, Factor SA. Movement disorders emergencies. Part 1: Hypokinetic disorders. Archives of Neurology. 68: 567-72. PMID 21555633 DOI: 10.1001/archneurol.2011.84  0.494
2010 Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT. Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 75: 2021-7. PMID 21115958 DOI: 10.1212/WNL.0b013e3181ff96dd  0.443
2009 Weiner W, Ahlskog E, Factor S, Suchowersky O, Reich S. Initiating therapy in Parkinson's disease Annals of Neurology. 65: 480-481. PMID 19399873 DOI: 10.1002/Ana.21667  0.568
2009 Hamza T, Factor S, Molho E, Montimurro J, Pratt D, Rosen A, Higgins D, Payami H. P2.110 Evidence for association of high-dose levodopa therapy with intellectual and psychiatric complications of Parkinson's disease Parkinsonism & Related Disorders. 15: S119. DOI: 10.1016/S1353-8020(09)70461-4  0.326
2008 Factor SA. The clinical spectrum of freezing of gait in atypical parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S431-8. PMID 18668624 DOI: 10.1002/mds.21849  0.342
2008 Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 134-9. PMID 18093156 DOI: 10.1111/J.1468-1331.2007.02012.X  0.326
2008 Factor SA, Lang AE, Weiner WJ. Preface Drug Induced Movement Disorders: Second Edition. xiii-xiv. DOI: 10.1002/9780470753217  0.36
2007 Esper CD, Weiner WJ, Factor SA. Progressive supranuclear palsy. Reviews in Neurological Diseases. 4: 209-16. PMID 18195676  0.512
2007 Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology. 68: 1108-15. PMID 17404192 DOI: 10.1212/01.Wnl.0000258660.74391.C1  0.342
2007 Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1061-8. PMID 17266092 DOI: 10.1002/Mds.21382  0.328
2007 Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, ... ... Factor S, et al. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement Disorders. 22: 254-257. PMID 17149721 DOI: 10.1002/Mds.21233  0.389
2007 Factor SA. Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson's disease patient while actively treated with deep brain stimulation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 148-9. PMID 17080464 DOI: 10.1002/mds.21172  0.329
2007 Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Appendix D: Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology Continuum Lifelong Learning in Neurology. 13: 177-189.  0.507
2006 Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, ... ... Factor S, et al. Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease Movement Disorders. 21: 2257-2260. PMID 17078063 DOI: 10.1002/Mds.21162  0.325
2006 Friedman JH, Berman RM, Goetz CG, Factor SA, Ondo WG, Wojcieszek J, Carson WH, Marcus RN. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 2078-81. PMID 17013906 DOI: 10.1002/mds.21091  0.406
2006 Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. American Journal of Human Genetics. 79: 752-8. PMID 16960813 DOI: 10.1086/508025  0.353
2006 Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 66: 983-95. PMID 16606909 DOI: 10.1212/01.wnl.0000215250.82576.87  0.504
2006 Huber VC, Mondal T, Factor SA, Seegal RF, Lawrence DA. Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression. Journal of Neuroinflammation. 3: 1. PMID 16426448 DOI: 10.1186/1742-2094-3-1  0.31
2004 Factor SA, Molho ES. Threatening auditory hallucinations and Cotard syndrome in Parkinson disease. Clinical Neuropharmacology. 27: 205-7. PMID 15602098 DOI: 10.1097/01.Wnf.0000144040.20600.C1  0.407
2004 Fernandez HH, Friedman JH, Lansang MC, Factor SA, Molho ES, Coskun DJ. Diabetes mellitus among parkinsonian patients treated chronically with clozapine. Parkinsonism & Related Disorders. 10: 439-41. PMID 15465403 DOI: 10.1016/J.Parkreldis.2004.04.007  0.38
2004 Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, ... ... Factor S, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of Neurology. 61: 1044-53. PMID 15262734 DOI: 10.1001/Archneur.61.7.1044  0.575
2004 Factor SA. Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease. Neurology. 62: S12-7. PMID 15037666 DOI: 10.1212/Wnl.62.6_Suppl_4.S12  0.485
2004 Stacy M, Factor S. Rapid treatment of "off" episodes: Will this change Parkinson's disease therapy? Neurology. 62: S1-S2. DOI: 10.1212/Wnl.62.6_Suppl_4.S1  0.309
2003 Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology. 60: 1756-61. PMID 12796526 DOI: 10.1212/01.Wnl.0000068010.82167.Cf  0.397
2002 Factor SA, Jennings DL, Molho ES, Marek KL. The natural history of the syndrome of primary progressive freezing gait. Archives of Neurology. 59: 1778-83. PMID 12433266 DOI: 10.1001/Archneur.59.11.1778  0.4
2002 Reddy S, Factor SA, Molho ES, Feustel PJ. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 676-81. PMID 12210856 DOI: 10.1002/Mds.10176  0.448
2002 Factor SA, Molho ES, Friedman JH. Risperidone and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 221-2. PMID 11835472 DOI: 10.1002/Mds.1258  0.462
2001 Molho ES, Factor SA. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis. Current Neurology and Neuroscience Reports. 1: 320-8. PMID 11898537 DOI: 10.1007/S11910-001-0085-8  0.424
2001 Frucht SJ, Fahn S, Greene PE, O'Brien C, Gelb M, Truong DD, Welsh J, Factor S, Ford B. The natural history of embouchure dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 899-906. PMID 11746620 DOI: 10.1002/Mds.1167  0.313
2001 Factor SA, Molho ES, Feustel PJ, Brown DL, Evans SM. Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's disease. Clinical Neuropharmacology. 24: 295-9. PMID 11586115 DOI: 10.1097/00002826-200109000-00007  0.482
2001 Factor SA. Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists. Current Treatment Options in Neurology. 3: 479-493. PMID 11581525 DOI: 10.1007/S11940-001-0011-Z  0.438
2001 Dewey RB, Hutton JT, LeWitt PA, Factor SA. A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events Archives of Neurology. 58: 1385-1392. PMID 11559309 DOI: 10.1001/Archneur.58.9.1385  0.393
2001 Factor SA, Lava NS. Focal myopathy as a cause of anterocollis in Parkinsonism Movement Disorders. 16: 754-756. PMID 11481704 DOI: 10.1002/Mds.1152  0.37
2001 Weiner WJ, Factor SA, Jankovic J, Hauser RA, Tetrud JW, Waters CH, Shulman LM, Glassman PM, Beck B, Paume D, Doyle C. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease. Parkinsonism & Related Disorders. 7: 115-120. PMID 11248592 DOI: 10.1016/S1353-8020(00)00031-6  0.628
2001 Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial Movement Disorders. 16: 135-139. PMID 11215574 DOI: 10.1002/1531-8257(200101)16:1<135::Aid-Mds1006>3.0.Co;2-Q  0.479
2001 FRIEDMAN J, FERNANDEZ H, FACTOR S. Treatment of Psychosis in Parkinson's Disease Journal of the American Medical Directors Association. 2: 99-99. DOI: 10.1016/S1525-8610(04)70170-X  0.456
2001 Friedman JH, Fernandez HH, Factor SA, Rangu S, Rowland FN. Treatment of psychosis in parkinson's disease (multiple letters) Journal of the American Medical Directors Association. 2: 99-100.  0.353
2000 Weiner WJ, Factor SA. Ropinirole as compared with levodopa in Parkinson's disease. The New England Journal of Medicine. 343: 885. PMID 11001687  0.58
2000 Hiner BC, Earnhart M, Yamamoto T, Frucht S, Weiner WJ, Factor SA, Rascol O. Ropinirole as compared with levodopa in Parkinson's disease [1] (multiple letters) New England Journal of Medicine. 343: 884-885. PMID 11001685 DOI: 10.1056/NEJM200009213431211  0.578
2000 Hauser RA, Friedlander J, Zesiewicz TA, Adler CH, Seeberger LC, O'Brien CF, Molho ES, Factor SA. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia Clinical Neuropharmacology. 23: 75-81. PMID 10803796 DOI: 10.1097/00002826-200003000-00003  0.373
2000 Factor SA. The initial treatment of Parkinson's disease (multiple letters) Movement Disorders. 15: 360-362. PMID 10752599 DOI: 10.1002/1531-8257(200003)15:2<360::Aid-Mds1033>3.0.Co;2-N  0.453
2000 Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis in parkinson's disease Movement Disorders. 15: 201-211. PMID 10752567 DOI: 10.1002/1531-8257(200003)15:2<201::Aid-Mds1001>3.0.Co;2-D  0.448
2000 Factor SA, Molho ES. Emergency department presentations of patients with Parkinson's disease American Journal of Emergency Medicine. 18: 209-215. PMID 10750935 DOI: 10.1016/S0735-6757(00)90023-8  0.476
2000 Factor SA, Brown DL, Molho ES. Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease Movement Disorders. 15: 167-169. PMID 10634261 DOI: 10.1002/1531-8257(200001)15:1<167::Aid-Mds1029>3.0.Co;2-8  0.372
1999 Molho ES, Factor SA. Worsening of motor features of parkinsonism with olanzapine Movement Disorders. 14: 1014-1016. PMID 10584679 DOI: 10.1002/1531-8257(199911)14:6<1014::Aid-Mds1017>3.0.Co;2-9  0.414
1999 Factor SA, Molho ES. Transient benefit of amantadine in Parkinson's disease: The facts about the myth Movement Disorders. 14: 515-517. PMID 10348482 DOI: 10.1002/1531-8257(199905)14:3<515::Aid-Mds1024>3.0.Co;2-Z  0.462
1999 Miyasaki JM, Grimes D, Lang AE, Factor SA, Molho ES, Brown DL. Acute delirium after withdrawal of amantadine in Parkinson's disease [5] (multiple letters) Neurology. 52: 1720-1721. PMID 10331717 DOI: 10.1212/Wnl.52.8.1717-D  0.392
1998 Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration Archives of Neurology. 55: 957-961. PMID 9678313 DOI: 10.1001/Archneur.55.7.957  0.374
1998 Molho ES, Feustel PJ, Factor SA. Clinical comparison of tardive and idiopathic cervical dystonia Movement Disorders. 13: 486-489. PMID 9613742 DOI: 10.1002/Mds.870130319  0.331
1998 Factor SA, Weiner WJ. 'Sleep benefit' in Parkinson's disease. Neurology. 50: 1514-5. PMID 9596032  0.494
1998 Factor SA, Molho ES, Brown DL. Acute delirium after withdrawal of amantadine in Parkinson's disease. Neurology. 50: 1456-8. PMID 9596005 DOI: 10.1212/WNL.50.5.1456  0.326
1998 Kieburtz K, Frey K, Albin R, Marek K, Bates G, Aylward E, Guttman M, Rouleau G, Baehr M, Pahwa R, Lyons KE, Wilkinson SB, Kieltyka J, Koller WC, Bertoni JM, ... ... Factor SA, et al. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis, and Treatment of Huntington's Disease, Queen Elizabeth Hotel, Montreal, Canada, 18 October 1998 Movement Disorders. 13: 858-863. DOI: 10.1002/Mds.870130522  0.554
1997 Hauser RA, Zesiewicz TA, Factor SA, Guttman M, Weiner WJ. Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness. Parkinsonism & Related Disorders. 3: 1-6. PMID 18591048 DOI: 10.1016/S1353-8020(96)00042-9  0.553
1997 Factor SA, Barron KD. Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 783-9. PMID 9380067 DOI: 10.1002/Mds.870120528  0.349
1997 Factor SA, Friedman JH. The emerging role of clozapine in the treatment of improvement disorders Movement Disorders. 12: 483-496. PMID 9251065 DOI: 10.1002/Mds.870120403  0.472
1997 Tarsy D, Kaufman D, Sethi KD, Rivner MH, Molho E, Factor S. An open-label study of botulinum toxin A for treatment of tardive dystonia Clinical Neuropharmacology. 20: 90-93. PMID 9037579 DOI: 10.1097/00002826-199702000-00012  0.359
1996 Podskalny GD, Factor SA. Chorea caused by lithium intoxication: A case report and literature review Movement Disorders. 11: 733-737. PMID 8914104 DOI: 10.1002/Mds.870110623  0.323
1995 Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos JR, Singer C, Shulman L, Brown D, Sheldon C. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. Journal of Neural Transmission. Supplementum. 45: 225-30. PMID 8748629  0.602
1995 Factor SA, Schneider AS. Peripheral catecholamine output in Parkinson's disease: Effects of drug treatment Experimental Neurology. 131: 64-68. PMID 7895813 DOI: 10.1016/0014-4886(95)90008-X  0.406
1995 Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states Advances in Neurology. 65: 115-138. PMID 7872135  0.307
1995 Factor SA, Molho ES, Brown DL. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease Journal of Neuropsychiatry and Clinical Neurosciences. 7: 304-307. PMID 7580188 DOI: 10.1176/Jnp.7.3.304  0.458
1995 Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: Frequency, clinical profile, and characteristics Journal of Neurology, Neurosurgery and Psychiatry. 59: 406-412. PMID 7561921 DOI: 10.1136/Jnnp.59.4.406  0.337
1994 Factor SA, Ortof E, Dentinger MP, Mankes R, Barron KD. Platelet morphology in Parkinson's disease: an electron microscopic study. Journal of the Neurological Sciences. 122: 84-9. PMID 8195808 DOI: 10.1016/0022-510X(94)90056-6  0.406
1994 Factor SA, Brown D, Molho ES, Podskalny GD. Clozapine: A 2-year open trial in parkinson’s disease patients with psychosis Neurology. 44: 544-546. PMID 8145929 DOI: 10.1212/Wnl.44.3_Part_1.544  0.476
1994 Factor SA, Podskalny GD, Barron KD. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. Journal of the Neurological Sciences. 127: 114-20. PMID 7699386 DOI: 10.1016/0022-510X(94)90144-9  0.375
1993 Factor SA. Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease Movement Disorders. 8: 240-241. PMID 8474504 DOI: 10.1002/Mds.870080231  0.447
1993 Weiner WJ, Factor SA, Sanchez-Ramos JR, Singer C, Sheldon C, Cornelius L, Ingenito A. Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease. Neurology. 43: 21-7. PMID 8423888 DOI: 10.1212/Wnl.43.1_Part_1.21  0.622
1993 Factor SA, Weiner WJ. Early combination therapy with bromocriptine and levodopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 8: 257-62. PMID 8341289 DOI: 10.1002/Mds.870080302  0.625
1993 Factor SA, Weiner WJ. Combination therapy for PD Neurology. 43: 2726-2726. DOI: 10.1212/WNL.43.12.2726  0.504
1992 Factor SA, Brown D. Clozapine prevents recurrence of psychosis in Parkinson's disease Movement Disorders. 7: 125-131. PMID 1350059 DOI: 10.1002/Mds.870070205  0.484
1991 Factor SA, Weiner WJ. Prior history of head trauma in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 225-9. PMID 1922127 DOI: 10.1002/Mds.870060306  0.532
1990 Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 280-5. PMID 2259351 DOI: 10.1002/Mds.870050404  0.586
1990 Factor SA, Sanchez-Ramos JR, Weiner WJ. Vitamin E therapy in Parkinson's disease. Advances in Neurology. 53: 457-61. PMID 2239484  0.524
1989 Sanchez-Ramos JR, Factor SA, Weiner WJ, Marquez J. Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 266-73. PMID 2779596 DOI: 10.1002/Mds.870040308  0.487
1989 Factor SA, Weiner WJ, Hefti F. Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease. Annals of Neurology. 26: 286-8. PMID 2774516 DOI: 10.1002/Ana.410260219  0.592
1989 Weiner WJ, Factor SA, Sanchez-Ramos JR. The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 732-5. PMID 2746265 DOI: 10.1136/Jnnp.52.6.732  0.544
1989 Factor SA, Sanchez-Ramos JR, Weiner WJ, Ingenito AM. Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 83-8. PMID 2709040 DOI: 10.1136/Jnnp.52.1.83  0.589
1989 Factor SA, Weiner WJ. Retrospective evaluation of vitamin E therapy in Parkinson's disease Annals of the New York Academy of Sciences. 570: 441-442. DOI: 10.1111/J.1749-6632.1989.Tb14951.X  0.572
1988 Factor SA, Sanchez-Ramos JR, Weiner WJ. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 529-33. PMID 3288717 DOI: 10.1136/Jnnp.51.4.529  0.599
1988 Factor SA, Sanchez-Ramos JR, Weiner WJ. Cocaine and Tourette's syndrome. Annals of Neurology. 23: 423-4. PMID 3164176 DOI: 10.1002/Ana.410230431  0.455
1988 Factor SA, Sanchez-Ramos J, Weiner WJ. Delayed-onset dystonia associated with corticospinal tract dysfunction. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 201-10. PMID 3057351 DOI: 10.1002/Mds.870030304  0.503
1988 Factor SA, Sanchez-Ramos J, Weiner WJ. Trauma as an etiology of parkinsonism: a historical review of the concept. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 30-6. PMID 3050470 DOI: 10.1002/Mds.870030105  0.603
1987 Weiner WJ, Factor SA, Sanchez-Ramos J, Berger J. A double-blind evaluation of ciladopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 2: 211-7. PMID 3332914 DOI: 10.1002/Mds.870020308  0.55
1987 Sanchez-Ramos JR, Factor SA, Weiner WJ. Paraquat and Parkinson's disease Neurology. 37: 1820-1820. DOI: 10.1212/WNL.37.11.1820-a  0.572
Low-probability matches (unlikely to be authored by this person)
2011 Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 564-8. PMID 20884673 DOI: 10.1136/Jnnp.2010.222042  0.299
2014 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... ... Factor SA, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/Jamaneurol.2013.4498  0.299
1999 Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A- resistant cervical dystonia Neurology. 53: 1431-1438. PMID 10534247 DOI: 10.1212/Wnl.53.7.1431  0.298
2018 Wallen ZD, Chen H, Hill-Burns EM, Factor SA, Zabetian CP, Payami H. Plasticity-related gene 3 () and age at diagnosis of Parkinson disease. Neurology. Genetics. 4: e271. PMID 30338293 DOI: 10.1212/Nxg.0000000000000271  0.298
2021 Lewis SJG, Factor SA, Giladi N, Hallett M, Nieuwboer A, Nutt JG, Przedborski S, Papa SM. Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34939228 DOI: 10.1002/mds.28837  0.298
2003 Factor SA, Troche-Panetto M, Weaver SA. Dystonia in AIDS: report of four cases. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1492-8. PMID 14673886 DOI: 10.1002/Mds.10602  0.297
2006 Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 519-23. PMID 16250030 DOI: 10.1002/Mds.20751  0.296
2018 Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool immune profiles evince gastrointestinal inflammation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29572994 DOI: 10.1002/Mds.27326  0.296
2008 Factor SA. Current status of symptomatic medical therapy in Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 5: 164-80. PMID 18394561 DOI: 10.1016/j.nurt.2007.12.001  0.295
2020 Bezchlibnyk YB, Sharma VD, Naik KB, Isbaine F, Gale JT, Cheng J, Triche SD, Miocinovic S, Buetefisch CM, Willie JT, Boulis NM, Factor SA, Wichmann T, DeLong MR, Gross RE. Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement. Journal of Neurosurgery. 1-11. PMID 32114534 DOI: 10.3171/2019.12.Jns192010  0.294
1997 Factor SA, Molho ES. Adult-onset tics associated with peripheral injury Movement Disorders. 12: 1052-1055. PMID 9399236 DOI: 10.1002/Mds.870120634  0.293
2011 Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W, Mollenhauer B, Sherer T, Frasier M, Meunier C, ... ... Factor S, et al. The Parkinson Progression Marker Initiative (PPMI) Progress in Neurobiology. 95: 629-635. PMID 21930184 DOI: 10.1016/J.Pneurobio.2011.09.005  0.293
2023 Tripathi R, McKay JL, Factor SA, Esper CD, Bernhard D, Testini P, Miocinovic S. Impact of deep brain stimulation on gait in Parkinson disease: A kinematic study. Gait & Posture. 108: 151-156. PMID 38070393 DOI: 10.1016/j.gaitpost.2023.12.002  0.291
1991 Tolge CF, Factor SA. Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome Movement Disorders. 6: 69-72. PMID 2005925 DOI: 10.1002/Mds.870060113  0.29
2015 Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/Mds.26161  0.29
2014 Payami H, Factor SA. Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 111-6. PMID 24258196 DOI: 10.1007/s13311-013-0237-y  0.29
1987 Factor SA, Sanchez-Ramos J, Weiner WJ, Lieberman A, Koslow M, Maestrone P, White RJ, Venna N, Sabin TD, Osserman EF, Drucker-Colin R, Madrazo-Navarro I. Adrenal grafts for Parkinson's disease New England Journal of Medicine. 317: 1091-1093. PMID 3657873  0.29
2019 Bong SM, McKay JL, Factor SA, Ting LH. Perception of whole-body motion during balance perturbations is impaired in Parkinson's disease and is associated with balance impairment. Gait & Posture. 76: 44-50. PMID 31731133 DOI: 10.1016/J.Gaitpost.2019.10.029  0.289
2010 Sethi K, Factor S, Watts R. Quality of life in parkinson's disease patients following adjunctive tolcapone therapy: Results of an open-label, multicenter, community-based trial Cns Spectrums. 15: 27-32. PMID 20394182  0.287
2010 Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism & Related Disorders. 16: 177-80. PMID 19939721 DOI: 10.1016/J.Parkreldis.2009.11.002  0.286
2000 Factor SA, Lew MF, Trosch RM. Current and emerging treatments for cervical dystonia. Cns Spectrums. 5: S1-8. PMID 18268461 DOI: 10.1017/S1092852900023695  0.285
2008 Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 401-4. PMID 18067180 DOI: 10.1002/mds.21854  0.284
2001 O'Brien C, Brashear A, Cullis P, Truong D, Molho E, Jenkins S, Wojcieszek J, O'Neil T, Factor S, Seeberger L. Cervical dystonia severity scale reliability study. Movement Disorders. 16: 1086-1090. PMID 11748739 DOI: 10.1002/Mds.1226  0.282
2015 Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, ... ... Factor SA, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/Mds.26065  0.281
2011 Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2190-5. PMID 21714002 DOI: 10.1002/Mds.23806  0.28
2021 Wallen ZD, Stone WJ, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Exploring human-genome gut-microbiome interaction in Parkinson's disease. Npj Parkinson's Disease. 7: 74. PMID 34408160 DOI: 10.1038/s41531-021-00218-2  0.279
1999 Molho ES, Factor SA. Possible tardive dystonia resulting from clozapine therapy Movement Disorders. 14: 873-874. PMID 10495056 DOI: 10.1002/1531-8257(199909)14:5<873::Aid-Mds1027>3.0.Co;2-U  0.278
2002 Adler CH, Factor SA, Brin M, Sethi KD. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 158-61. PMID 11835455 DOI: 10.1002/Mds.10001  0.277
2007 Esper CD, Factor SA. Current and future treatments in multiple system atrophy. Current Treatment Options in Neurology. 9: 210-23. PMID 17445499 DOI: 10.1007/BF02938411  0.276
2014 Factor SA, Scullin MK, Sollinger AB, Land JO, Wood-Siverio C, Zanders L, Freeman A, Bliwise DL, McDonald WM, Goldstein FC. Cognitive correlates of hallucinations and delusions in Parkinson's disease. Journal of the Neurological Sciences. 347: 316-21. PMID 25466695 DOI: 10.1016/J.Jns.2014.10.033  0.275
2013 Scullin MK, Sollinger AB, Land J, Wood-Siverio C, Zanders L, Lee R, Freeman A, Goldstein FC, Bliwise DL, Factor SA. Sleep and impulsivity in Parkinson's disease. Parkinsonism & Related Disorders. 19: 991-4. PMID 23880026 DOI: 10.1016/J.Parkreldis.2013.06.018  0.275
2015 Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, et al. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26260437 DOI: 10.1002/Mds.26325  0.275
2009 Kay D, Montimurro J, Schlossmacher M, Bresnick E, Stevens C, Zabetian C, Factor S, Higgins D, Scherzer C, Payami H. P3.039 Polymorphisms in the transcription factor gene GATA2 and GATA-2 target region in a-synuclein (SNCA) are associated with Parkinson's disease (PD) Parkinsonism & Related Disorders. 15: S158. DOI: 10.1016/S1353-8020(09)70603-0  0.274
2017 Huddleston DE, Langley J, Sedlacik J, Boelmans K, Factor SA, Hu XP. In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. Human Brain Mapping. PMID 28240402 DOI: 10.1002/hbm.23547  0.273
2014 Bliwise DL, Scullin MK, Factor SA. Internal consistency of the University of Michigan RBD Questionnaire. Journal of Neurology. 261: 1439-41. PMID 24916829 DOI: 10.1007/S00415-014-7392-X  0.27
2014 Hill-Burns EM, Wissemann WT, Hamza TH, Factor SA, Zabetian CP, Payami H. Identification of a novel Parkinson's disease locus via stratified genome-wide association study. Bmc Genomics. 15: 118. PMID 24511991 DOI: 10.1186/1471-2164-15-118  0.267
2023 Agharazi H, Hardin EC, Flannery K, Beylergil SB, Noecker A, Kilbane C, Factor SA, McIntyre C, Shaikh AG. Physiological measures and anatomical correlates of subthalamic deep brain stimulation effect on gait in Parkinson's disease. Journal of the Neurological Sciences. 449: 120647. PMID 37100017 DOI: 10.1016/j.jns.2023.120647  0.263
2010 Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, ... ... Factor SA, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genetics. 42: 781-5. PMID 20711177 DOI: 10.1038/Ng.642  0.262
2020 Richardson RM, Bankiewicz KS, Christine CW, Van Laar AD, Gross RE, Lonser R, Factor SA, Kostyk SK, Kells AP, Ravina B, Larson PS. Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32732384 DOI: 10.1136/Jnnp-2020-322904  0.262
2016 Langley J, Huddleston DE, Merritt M, Chen X, McMurray R, Silver M, Factor SA, Hu X. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited. Human Brain Mapping. PMID 27029026 DOI: 10.1002/Hbm.23192  0.26
1993 Molho ES, Factor SA. Basal ganglia infarction as a possible cause of cervical dystonia Movement Disorders. 8: 213-216. PMID 8474493 DOI: 10.1002/Mds.870080219  0.26
2006 Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing. 10: 221-7. PMID 17020475 DOI: 10.1089/Gte.2006.10.221  0.26
2016 Sampat R, Young S, Rosen A, Bernhard D, Millington D, Factor S, Jinnah HA. Potential mechanisms for low uric acid in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 123: 365-70. PMID 26747026 DOI: 10.1007/s00702-015-1503-4  0.259
2010 Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism & Related Disorders. 16: 438-41. PMID 20494607 DOI: 10.1016/j.parkreldis.2010.04.007  0.258
2020 Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Parkinson's Disease. 6: 11. PMID 32566740 DOI: 10.1038/S41531-020-0112-6  0.258
2012 Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 78: 1229-36. PMID 22496199 DOI: 10.1212/Wnl.0B013E3182516244  0.258
2020 Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Parkinson's Disease. 6: 11. PMID 33579999 DOI: 10.1038/s41531-020-0112-6  0.258
2015 Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/S13024-015-0045-4  0.257
2010 Factor S, Mark MH, Watts R, Struck L, Mori A, Ballerini R, Sussman NM. A long-term study of istradefylline in subjects with fluctuating Parkinson's disease Parkinsonism and Related Disorders. 16: 423-426. PMID 20338800 DOI: 10.1016/j.parkreldis.2010.02.014  0.257
2016 Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, Lynch T, Wszolek ZK, Silburn PA, Mellick GD, Ritz B, Scherzer CR, Zabetian CP, Factor SA, Breheny PJ, et al. Identification of genetic modifiers of age-at-onset for familial Parkinson's disease. Human Molecular Genetics. PMID 27402877 DOI: 10.1093/Hmg/Ddw206  0.254
2008 Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clinical Neuropharmacology. 31: 127-33. PMID 18520979 DOI: 10.1097/Wnf.0B013E3180Ca77Ea  0.254
2023 Block CK, Patel M, Risk BB, Staikova E, Loring D, Esper CD, Scorr L, Higginbotham L, Aia P, DeLong MR, Wichmann T, Factor SA, Au Yong N, Willie JT, Boulis NM, et al. Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case-Control Study. Movement Disorders Clinical Practice. 10: 382-391. PMID 36949802 DOI: 10.1002/mdc3.13660  0.254
2010 Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Archives of Neurology. 67: 154-60. PMID 20142523 DOI: 10.1001/Archneurol.2009.334  0.254
2022 Lewis S, Factor S, Giladi N, Nieuwboer A, Nutt J, Hallett M. Stepping up to meet the challenge of freezing of gait in Parkinson's disease. Translational Neurodegeneration. 11: 23. PMID 35490252 DOI: 10.1186/s40035-022-00298-x  0.253
1999 Factor SA. Dopamine agonists Medical Clinics of North America. 83: 415-443. PMID 10093586 DOI: 10.1016/S0025-7125(05)70112-7  0.253
2011 Richardson JR, Roy A, Shalat SL, Buckley B, Winnik B, Gearing M, Levey AI, Factor SA, O'Suilleabhain P, German DC. β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease. Neurotoxicology. 32: 640-5. PMID 21620887 DOI: 10.1016/J.Neuro.2011.04.002  0.253
2018 Fernandez HH, Davis MD, Factor SA, Hauser RA, Jarskog LF, Jimenez-Shahed J, Kumar R, Ochudlo S, Ondo WG, Anderson KE. 134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies Cns Spectrums. 23: 84-84. DOI: 10.1017/S1092852918000305  0.251
2002 Factor SA. Pharmacology of atypical antipsychotics. Clinical Neuropharmacology. 25: 153-7. PMID 12023569 DOI: 10.1097/00002826-200205000-00005  0.251
2020 Brownstein MJ, Simon NG, Long JD, Yankey J, Maibach HT, Cudkowicz M, Coffey C, Conwit RA, Lungu C, Anderson KE, Hersch SM, Ecklund DJ, Damiano EM, Itzkowitz DE, Lu S, ... ... Factor S, et al. Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial. Journal of Clinical Medicine. 9. PMID 33207828 DOI: 10.3390/jcm9113682  0.249
2006 Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology. 66: 411-4. PMID 16476942 DOI: 10.1212/01.Wnl.0000196469.52995.Ab  0.247
2005 Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Annals of Neurology. 57: 462-3. PMID 15732096 DOI: 10.1002/Ana.20389  0.246
2011 Huddleston DE, Factor SA. Of monkeys and men: analysis of the phase 2 double-blind, sham-surgery controlled, randomized trial of AAV2-neurturin gene therapy for Parkinson's disease. Current Neurology and Neuroscience Reports. 11: 345-8. PMID 21505812 DOI: 10.1007/s11910-011-0206-y  0.246
2008 Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 1222-30. PMID 18404644 DOI: 10.1002/Ajmg.B.30758  0.245
2017 Jacova C, Factor SA. Phosphodiesterase 4: Rethinking cognition in Parkinson disease. Neurology. PMID 28701498 DOI: 10.1212/Wnl.0000000000004221  0.245
2020 Martino G, McKay JL, Factor SA, Ting LH. Neuromechanical Assessment of Activated vs. Resting Leg Rigidity Using the Pendulum Test Is Associated With a Fall History in People With Parkinson's Disease. Frontiers in Human Neuroscience. 14: 602595. PMID 33362496 DOI: 10.3389/fnhum.2020.602595  0.244
2013 Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E. Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 817-20. PMID 23589371 DOI: 10.1002/mds.25395  0.242
2007 Rosen AR, Steenland NK, Hanfelt J, Factor SA, Lah JJ, Levey AI. Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history. Neurogenetics. 8: 263-70. PMID 17805588 DOI: 10.1007/S10048-007-0100-6  0.239
2017 Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, Grigoryan N, Factor SA, West AB, Boss JM, Tansey MG. LRRK2 levels in immune cells are increased in Parkinson's disease. Npj Parkinson's Disease. 3: 11. PMID 28649611 DOI: 10.1038/S41531-017-0010-8  0.238
2012 Alcalay R, Rosado L, Mejia-Santana H, Orbe-Reilly M, Caccappolo E, Tang M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Factor S, et al. Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study (IN10-2.001) Neurology. 78: IN10-2.001-IN10-2.00. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In10-2.001  0.235
2007 Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, Schellenberg GD, Payami H. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Annals of Neurology. 61: 47-54. PMID 17187375 DOI: 10.1002/Ana.21039  0.234
2016 Sampat R, Young S, Rosen A, Bernhard D, Millington D, Factor S, Jinnah HA. Potential mechanisms for low uric acid in Parkinson disease Journal of Neural Transmission. 1-6. DOI: 10.1007/s00702-015-1503-4  0.232
2023 Block CK, Patel M, Risk BB, Staikova E, Loring D, Esper CD, Scorr L, Higginbotham L, Aia P, De Long MR, Wichmann T, Factor SA, Au Yong N, Willie JT, Boulis NM, et al. Reply: Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations. Movement Disorders Clinical Practice. 10: 1235-1236. PMID 37635771 DOI: 10.1002/mdc3.13818  0.23
2021 McKay JL, Lang KC, Bong SM, Hackney ME, Factor SA, Ting LH. Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease. Plos One. 16: e0252119. PMID 34043678 DOI: 10.1371/journal.pone.0252119  0.23
1996 Molho ES, Factor SA, Podskalny GD, Brown D. The effect of dancing on dystonia Movement Disorders. 11: 225-227. PMID 8684398 DOI: 10.1002/Mds.870110220  0.228
2012 Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, ... ... Factor SA, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. Plos Genetics. 8: e1002548. PMID 22438815 DOI: 10.1371/Journal.Pgen.1002548  0.227
1991 Factor SA, Matthews MK. Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy Southern Medical Journal. 84: 626-628. PMID 2035085  0.225
2010 Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology. 67: 1350-6. PMID 21060011 DOI: 10.1001/Archneurol.2010.279  0.225
2017 Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, McEvoy JP, Ochudlo S, Ondo WG, Fernandez HH. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet. Psychiatry. PMID 28668671 DOI: 10.1016/S2215-0366(17)30236-5  0.224
2014 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. Jama Neurology. 71: 1405-12. PMID 25178429 DOI: 10.1001/Jamaneurol.2014.1455  0.224
2023 Kwon H, Clifford GD, Genias I, Bernhard D, Esper CD, Factor SA, McKay JL. An Explainable Spatial-Temporal Graphical Convolutional Network to Score Freezing of Gait in Parkinsonian Patients. Sensors (Basel, Switzerland). 23. PMID 36850363 DOI: 10.3390/s23041766  0.223
2015 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/Mds.26359  0.222
2013 Hill-Burns EM, Singh N, Ganguly P, Hamza TH, Montimurro J, Kay DM, Yearout D, Sheehan P, Frodey K, McLear JA, Feany MB, Hanes SD, Wolfgang WJ, Zabetian CP, Factor SA, et al. A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. The Pharmacogenomics Journal. 13: 530-7. PMID 23032990 DOI: 10.1038/Tpj.2012.38  0.222
2012 Marder K, Tang M, Alcalay R, Rosado L, Mejia-Santana H, Caccappolo E, Ruiz D, Orbe-Reilly M, Ross B, Louis E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, ... ... Factor S, et al. Estimating the Cumulative Risk of PD in Carriers of Parkin Mutations: The CORE-PD Study (PD4.007) Neurology. 78: PD4.007-PD4.007. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pd4.007  0.222
2010 Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 75: 1189-94. PMID 20876472 DOI: 10.1212/Wnl.0B013E3181F4D832  0.219
2018 Huddleston DE, Langley J, Dusek P, He N, Faraco CC, Crosson B, Factor S, Hu XP. Imaging Parkinsonian Pathology in Substantia Nigra with MRI Current Radiology Reports. 6. DOI: 10.1007/S40134-018-0272-X  0.219
2009 Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Occupation and risk of parkinsonism: a multicenter case-control study. Archives of Neurology. 66: 1106-13. PMID 19752299 DOI: 10.1001/archneurol.2009.195  0.219
2012 Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, et al. Head injury, α-synuclein Rep1, and Parkinson's disease. Annals of Neurology. 71: 40-8. PMID 22275250 DOI: 10.1002/ana.22499  0.218
2015 Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, Paul KC, Ritz B, Bronstein J, Factor SA, Boss JM, Tansey MG. Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study. Npj Parkinson's Disease. 1. PMID 27148593 DOI: 10.1038/Npjparkd.2015.2  0.217
2023 Kwon H, Clifford GD, Genias I, Bernhard D, Esper CD, Factor SA, McKay JL. An explainable spatial-temporal graphical convolutional network to score freezing of gait in parkinsonian patients. Medrxiv : the Preprint Server For Health Sciences. PMID 36711809 DOI: 10.1101/2023.01.13.23284535  0.217
2014 Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: therapeutic options for an increasingly common disorder. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 166-76. PMID 24310603 DOI: 10.1007/s13311-013-0222-5  0.214
2020 Caroff SN, Lindenmayer JP, Marder SR, Factor SA, Farahmand K, Lundt L. 139 Early Response with Valbenazine and Long-Term Symptom Reduction in Patients with Tardive Dyskinesia: Post Hoc Analysis of the KINECT 3 Study. Cns Spectrums. 25: 288-289. PMID 32331018 DOI: 10.1017/S1092852920000553  0.214
2008 McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H. Exploring gene-environment interactions in Parkinson's disease. Human Genetics. 123: 257-65. PMID 18210157 DOI: 10.1007/S00439-008-0466-Z  0.213
2011 Evatt ML, Freeman A, Factor S. Adult-onset dystonia. Handbook of Clinical Neurology. 100: 481-511. PMID 21496604 DOI: 10.1016/B978-0-444-52014-2.00037-9  0.212
2014 Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1258-64. PMID 25073717 DOI: 10.1002/Mds.25924  0.211
2012 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Factor S, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/Wnl.0B013E318253D54B  0.21
2015 Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, et al. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease. Parkinsonism & Related Disorders. 21: 692-7. PMID 25943529 DOI: 10.1016/J.Parkreldis.2015.04.002  0.21
2018 Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D. Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30387904 DOI: 10.1002/Mds.27488  0.21
2015 Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57. PMID 26061140 DOI: 10.1002/Ana.24436  0.208
2014 Zutshi D, Cloud LJ, Factor SA. Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 4: 266. PMID 25374768 DOI: 10.7916/D8MS3R8C  0.205
2013 Bliwise DL, Trotti LM, Juncos JJ, Factor SA, Freeman A, Rye DB. Daytime REM sleep in Parkinson's disease. Parkinsonism & Related Disorders. 19: 101-3. PMID 22939103 DOI: 10.1016/J.Parkreldis.2012.08.003  0.204
2017 Mata IF, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Espay AJ, Revilla FJ, et al. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease. Neurobiology of Aging. PMID 28526295 DOI: 10.1016/J.Neurobiolaging.2017.04.009  0.2
2011 Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, Tenesa A, Kusel VI, Sheehan P, Eaaswarkhanth M, Yearout D, Samii A, Roberts JW, Agarwal P, Bordelon Y, ... ... Factor SA, et al. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. Plos Genetics. 7: e1002237. PMID 21876681 DOI: 10.1371/Journal.Pgen.1002237  0.2
2002 Factor SA. Cervical dystonia in twins. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 846-7. PMID 12210893 DOI: 10.1002/Mds.10215  0.198
2024 Chen Z, Chen J, Mori W, Yi Y, Rong J, Li Y, Leon ERC, Shao T, Song Z, Yamasaki T, Ishii H, Zhang Y, Kokufuta T, Hu K, Xie L, ... ... Factor S, et al. Preclinical Evaluation of Novel Positron Emission Tomography (PET) Probes for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2). Journal of Medicinal Chemistry. PMID 38305157 DOI: 10.1021/acs.jmedchem.3c01687  0.198
2015 Scullin MK, Fairley JA, Trotti LM, Goldstein FC, Factor SA, Bliwise DL. Sleep correlates of trait executive function and memory in Parkinson's disease. Journal of Parkinson's Disease. 5: 49-54. PMID 25588355 DOI: 10.3233/Jpd-140475  0.197
2016 Snijders AH, Takakusaki K, Debu B, Lozano AM, Krishna V, Fasano A, Aziz TZ, Papa SM, Factor SA, Hallett M. Physiology of freezing of gait. Annals of Neurology. PMID 27649270 DOI: 10.1002/Ana.24778  0.197
2011 Aia PG, Revuelta GJ, Cloud LJ, Factor SA. Tardive dyskinesia. Current Treatment Options in Neurology. 13: 231-41. PMID 21365202 DOI: 10.1007/s11940-011-0117-x  0.197
2015 Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurologic Clinics. 33: 77-100. PMID 25432724 DOI: 10.1016/j.ncl.2014.09.002  0.197
2011 Hill-Burns EM, Hamza TH, Zabetian CP, Factor SA, Payami H. An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: e107-8; author reply. PMID 21834891 DOI: 10.1111/J.1468-1331.2011.03464.X  0.196
2014 Hamza TH, Hill-Burns EM, Scott WK, Vance JM, Factor SA, Zabetian CP, Payami H. Glutamate receptor gene GRIN2A, coffee, and Parkinson disease. Plos Genetics. 10: e1004774. PMID 25411979 DOI: 10.1371/Journal.Pgen.1004774  0.195
2016 McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, ... ... Factor SA, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. PMID 27913695 DOI: 10.1212/Wnl.0000000000003478  0.195
2016 Factor SA, Bennett A, Hohler AD, Wang D, Miyasaki JM. Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary. Neurology. PMID 27170564 DOI: 10.1212/WNL.0000000000002670  0.194
2019 Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL. Recent developments in drug-induced movement disorders: a mixed picture. The Lancet. Neurology. PMID 31279747 DOI: 10.1016/S1474-4422(19)30152-8  0.193
2012 Revuelta GJ, Cloud L, Aia PG, Factor SA. Tardive Dyskinesias Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. 331-352. DOI: 10.1002/9781444346183.ch21  0.193
2020 Factor SA. Management of Tardive Syndrome: Medications and Surgical Treatments. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 32720245 DOI: 10.1007/s13311-020-00898-3  0.192
2018 Anderson KE, Davis MD, Factor SA, Hauser RA, Jarskog LF, Jimenez-Shahed J, Kumar R, Ochudlo S, Ondo WG, Fernandez HH. 158 Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study Cns Spectrums. 23: 97-97. DOI: 10.1017/S1092852918000500  0.191
1997 Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD. Botulinum toxin type b: A double-blind, placebo controlled, safety and efficacy study in cervical dystonia Neurology. 49: 701-707. PMID 9305326  0.19
2008 Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 88-95. PMID 17987647 DOI: 10.1002/Mds.21782  0.19
1999 Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A- responsive cervical dystonia Neurology. 53: 1439-1446. PMID 10534248  0.187
2013 Tiderington E, Goodman EM, Rosen AR, Hapner ER, Johns MM, Evatt ML, Freeman A, Factor S, Jinnah HA. How long does it take to diagnose cervical dystonia? Journal of the Neurological Sciences. 335: 72-4. PMID 24034410 DOI: 10.1016/J.Jns.2013.08.028  0.187
2007 Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62: 137-44. PMID 17514749 DOI: 10.1002/Ana.21157  0.184
2021 Scorr LM, Factor SA, Parra SP, Kaye R, Paniello RC, Norris SA, Perlmutter JS, Bäumer T, Usnich T, Berman BD, Mailly M, Roze E, Vidailhet M, Jankovic J, LeDoux MS, et al. Oromandibular Dystonia: A Clinical Examination of 2,020 Cases. Frontiers in Neurology. 12: 700714. PMID 34603182 DOI: 10.3389/fneur.2021.700714  0.183
2016 Hatcher-Martin JM, Armstrong KA, Scorr LM, Factor SA. Propranolol therapy for Tardive dyskinesia: A retrospective examination. Parkinsonism & Related Disorders. PMID 27622970 DOI: 10.1016/j.parkreldis.2016.09.004  0.181
2015 Munhoz RP, Scorr LM, Factor SA. Movement disorders emergencies. Current Opinion in Neurology. 28: 406-12. PMID 26110802 DOI: 10.1097/WCO.0000000000000212  0.18
2023 Cotton AC, Scorr L, McDonald W, Comella C, Perlmutter JS, Goetz CG, Jankovic J, Marsh L, Factor S, Jinnah HA. Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient? Movement Disorders Clinical Practice. 10: 1399-1403. PMID 37772296 DOI: 10.1002/mdc3.13827  0.178
2012 Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of Neurology. 71: 370-84. PMID 22451204 DOI: 10.1002/Ana.22687  0.177
2005 Factor SA, Molho ES, Evans S, Feustel PJ. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1152-60. PMID 15954134 DOI: 10.1002/mds.20531  0.176
2006 Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8  0.176
2020 Fernandez HH, Barkay H, Hauser RA, Factor SA, Jimenez-Shahed J, Gross N, Marinelli L, Gordon MF, Savola JM, Anderson KE. 151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study. Cns Spectrums. 25: 296-297. PMID 32331030 DOI: 10.1017/S109285292000067X  0.173
2014 Chen X, Huddleston DE, Langley J, Ahn S, Barnum CJ, Factor SA, Levey AI, Hu X. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magnetic Resonance Imaging. 32: 1301-6. PMID 25086330 DOI: 10.1016/J.Mri.2014.07.003  0.171
2018 Scorr LM, Factor SA. VMAT2 inhibitors for the treatment of tardive dyskinesia. Journal of the Neurological Sciences. PMID 29433808 DOI: 10.1016/j.jns.2018.02.006  0.17
2016 Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, ... ... Factor SA, et al. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. Jama. 316: 40-50. PMID 27380342 DOI: 10.1001/Jama.2016.8655  0.17
2016 Jinnah HA, Goodmann E, Rosen AR, Evatt M, Freeman A, Factor S. Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes. Journal of Neurology. PMID 27113604 DOI: 10.1007/s00415-016-8136-x  0.169
1991 Factor SA, Coni RJ, Cowger M, Rosenblum EL. Paroxysmal tremor and orofacial dyskinesia secondary to a biopterin synthesis defect Neurology. 41: 930-932. PMID 2046945  0.168
2010 Cloud L, Helmers S, Jones R, Factor S, Testa C. Poster 3: Frequency of Epileptic Seizures in a Population of Juvenile Huntington's Disease Patients Neurotherapeutics. 7: 138-139. DOI: 10.1016/j.nurt.2009.09.004  0.167
2009 Payami H, Kay D, Stevens C, Montimurro J, Hamza T, Zabetian C, Factor S, Higgins D, Moses L, Zareparsi S, Schellenberg G, Nutt J. P2.067 Resolving mode-of-inheritance and association of PRKN with PD in a comprehensive sequence and copy-number-variation (CNV) analysis of 3800 subjects Parkinsonism & Related Disorders. 15: S106-S107. DOI: 10.1016/S1353-8020(09)70418-3  0.167
2017 Sharma VD, Jones R, Factor SA. Psychodynamic Psychotherapy for Functional (Psychogenic) Movement Disorders. Journal of Movement Disorders. 10: 40-44. PMID 28122424 DOI: 10.14802/jmd.16038  0.165
2018 Scorr LM, Silver MR, Hanfelt J, Sperin E, Freeman A, Jinnah HA, Factor SA. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 29542022 DOI: 10.1007/S13311-018-0620-9  0.164
2019 Mack J, Marsh L, Factor SA, McDonald WM. DIAGNOSTIC CONSIDERATIONS IN EVALUATING GERIATRIC PATIENTS WITH MOVEMENT DISORDERS The American Journal of Geriatric Psychiatry. 27: S6-S7. DOI: 10.1016/j.jagp.2019.01.142  0.161
2007 Cao X, Liang L, Hadcock JR, Iredale PA, Griffith DA, Menniti FS, Factor S, Greenamyre JT, Papa SM. Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 323: 318-26. PMID 17630359 DOI: 10.1124/jpet.107.125666  0.161
2020 Hauser RA, Barkay H, Fernandez HH, Factor SA, Jimenez-Shahed J, Gross N, Marinelli L, Forrest Gordon M, Savola JM, Anderson KE. 134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study. Cns Spectrums. 25: 284-285. PMID 32331048 DOI: 10.1017/S1092852920000504  0.16
2021 Esper CD, Scorr L, Papazian S, Bartholomew D, Esper GJ, Factor SA. Telemedicine in an Academic Movement Disorders Center during COVID-19. Journal of Movement Disorders. 14: 119-125. PMID 33725762 DOI: 10.14802/jmd.20099  0.159
2014 Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, et al. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1171-80. PMID 24838182 DOI: 10.1002/mds.25895  0.157
2023 Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag A. Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37081740 DOI: 10.1002/mds.29392  0.157
2017 Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O'Brien CF. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia. The American Journal of Psychiatry. appiajp201716091037. PMID 28320223 DOI: 10.1176/appi.ajp.2017.16091037  0.157
2019 Hauser RA, Fernandez HH, Stamler D, Davis MD, Factor SA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, LeDoux MS, Shprecher DR, Anderson KE. 45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study. Cns Spectrums. 24: 200-201. PMID 30859973 DOI: 10.1017/S1092852919000385  0.156
2022 Hauser RA, Barkay H, Fernandez HH, Factor SA, Jimenez-Shahed J, Gross N, Marinelli L, Wilhelm A, Alexander J, Gordon MF, Savola JM, Anderson KE. Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study. Frontiers in Neurology. 13: 773999. PMID 35280262 DOI: 10.3389/fneur.2022.773999  0.153
2012 Revuelta GJ, Benatar M, Freeman A, Wichmann T, Jinnah HA, DeLong MR, Factor SA. Clinical subtypes of anterocollis in parkinsonian syndromes. Journal of the Neurological Sciences. 315: 100-3. PMID 22133481 DOI: 10.1016/j.jns.2011.11.017  0.151
2008 Delong MR, Factor SA. Advanced therapies for movement disorders in neurotherapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 5: 163. PMID 18394560 DOI: 10.1016/j.nurt.2008.02.005  0.151
2015 O'Brien CF, Jimenez R, Hauser RA, Factor SA, Burke J, Mandri D, Castro-Gayol JC. NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1681-7. PMID 26346941 DOI: 10.1002/mds.26330  0.151
2021 Wadon ME, Bailey GA, Yilmaz Z, Hubbard E, AlSaeed M, Robinson A, McLauchlan D, Barbano RL, Marsh L, Factor SA, Fox SH, Adler CH, Rodriguez RL, Comella CL, Reich SG, et al. Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia. Brain and Behavior. PMID 34291595 DOI: 10.1002/brb3.2292  0.15
2021 Hauser RA, Barkay H, Fernandez HH, Factor SA, Jimenez-Shahed J, Gross N, Marinelli L, Wilhelm A, Gordon MF, Savola JM, Anderson KE. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. Cns Spectrums. 26: 162. PMID 34127136 DOI: 10.1017/S1092852920002606  0.149
2013 Wissemann WT, Hill-Burns EM, Zabetian CP, Factor SA, Patsopoulos N, Hoglund B, Holcomb C, Donahue RJ, Thomson G, Erlich H, Payami H. Association of Parkinson disease with structural and regulatory variants in the HLA region. American Journal of Human Genetics. 93: 984-93. PMID 24183452 DOI: 10.1016/J.Ajhg.2013.10.009  0.148
2017 Rommelfanger KS, Factor SA, LaRoche S, Rosen P, Young R, Rapaport MH. Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future. Frontiers in Neurology. 8: 106. PMID 28424653 DOI: 10.3389/Fneur.2017.00106  0.144
2019 Tripathi R, Reich SG, Scorr L, Guardiani E, Factor SA. Lurasidone-Induced Tardive Syndrome. Movement Disorders Clinical Practice. 6: 601-604. PMID 31538095 DOI: 10.1002/Mdc3.12812  0.144
2015 Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS, Cross S, Ryan P, Epping EA, Chiu E, Preston J, Goh A, Antonopoulos S, ... ... Factor SA, et al. Intra-individual variability in prodromal Huntington disease and its relationship to genetic burden Journal of the International Neuropsychological Society. 21: 8-21. DOI: 10.1017/S1355617714001076  0.142
2005 Murphy MA, Friedman JH, Tetrud JW, Factor SA. Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 12: 941-5. PMID 16289932 DOI: 10.1016/j.jocn.2004.10.013  0.141
2010 Payami H, Kay DM, Zabetian CP, Schellenberg GD, Factor SA, McCulloch CC. Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease. Genetic Epidemiology. 34: 92-9. PMID 19582778 DOI: 10.1002/Gepi.20439  0.141
2000 Higgins JJ, Golbe LI, De Biase A, Jankovic J, Factor SA, Adler RL. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy Neurology. 55: 1364-1367. PMID 11087782 DOI: 10.1212/Wnl.55.9.1364  0.139
2017 Fernandez HH, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Meltzer HY, Woods SW, Bega D, LeDoux MS, Shprecher DR, Davis C, Davis MD, Stamler D, Anderson KE. Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study. Neurology. PMID 28446646 DOI: 10.1212/Wnl.0000000000003960  0.139
2009 Trotti LM, Esper CD, Feustel PJ, Bliwise DL, Factor SA. Excessive daytime sleepiness in cervical dystonia. Parkinsonism & Related Disorders. 15: 784-6. PMID 19447065 DOI: 10.1016/j.parkreldis.2009.04.007  0.138
2012 Factor SA. Propranolol therapy for tardive dyskinesia revisited. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1703. PMID 23192928 DOI: 10.1002/mds.25231  0.131
2013 Reich SG, Factor S. William J. Weiner, MD (1945-2012) Neurology. 81: 1570-1571. DOI: 10.1212/01.Wnl.0000435289.11480.25  0.131
2020 Hauser RA, Meyer JM, Factor SA, Comella CL, Tanner CM, Xavier RM, Caroff SN, Lundt L. Differentiating Tardive Dyskinesia: A Video-Based Review of Antipsychotic-Induced Movement Disorders in Clinical Practice. Cns Spectrums. 1-29. PMID 33213556 DOI: 10.1017/S109285292000200X  0.129
2014 Revuelta GJ, Montilla J, Benatar M, Freeman A, Wichmann T, Jinnah HA, Delong MR, Factor SA. An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis. Journal of the Neurological Sciences. 340: 174-7. PMID 24725739 DOI: 10.1016/j.jns.2014.03.023  0.129
2022 Scorr LM, Cho HJ, Kilic-Berkmen G, McKay JL, Hallett M, Klein C, Baumer T, Berman BD, Feuerstein JS, Perlmutter JS, Berardelli A, Ferrazzano G, Wagle-Shukla A, Malaty IA, Jankovic J, ... ... Factor S, et al. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 1. PMID 36248010 DOI: 10.3389/dyst.2022.10359  0.126
2014 Scullin MK, Harrison TL, Factor SA, Bliwise DL. A Neurodegenerative Disease Sleep Questionnaire: principal component analysis in Parkinson's disease. Journal of the Neurological Sciences. 336: 243-6. PMID 24074551 DOI: 10.1016/J.Jns.2013.09.009  0.12
2013 Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR. The focal dystonias: current views and challenges for future research. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 926-43. PMID 23893450 DOI: 10.1002/Mds.25567  0.119
2019 Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, LeDoux MS, Shprecher DR, Anderson KE. 46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study. Cns Spectrums. 24: 201. PMID 30859974 DOI: 10.1017/S1092852919000397  0.119
2014 Shaikh AG, Mewes K, Jinnah HA, DeLong MR, Gross RE, Triche S, Freeman A, Factor SA. Globus pallidus deep brain stimulation for adult-onset axial dystonia. Parkinsonism & Related Disorders. 20: 1279-82. PMID 25260969 DOI: 10.1016/j.parkreldis.2014.09.005  0.119
2022 Ticku H, Fotedar N, Juncos J, Factor SA, Shaikh AG. Pseudonystagmus in progressive supranuclear palsy. Journal of the Neurological Sciences. 434: 120157. PMID 35131549 DOI: 10.1016/j.jns.2022.120157  0.119
2009 Molho ES, Agarwal N, Regan K, Higgins DS, Factor SA. Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1384-7. PMID 19441129 DOI: 10.1002/Mds.22622  0.118
2022 Zhang Z, Cisneros E, Lee HY, Vu JP, Chen Q, Benadof CN, Whitehill J, Rouzbehani R, Sy DT, Huang JS, Sejnowski TJ, Jankovic J, Factor S, Goetz CG, Barbano RL, et al. Hold that pose: capturing cervical dystonia's head deviation severity from video. Annals of Clinical and Translational Neurology. PMID 35333449 DOI: 10.1002/acn3.51549  0.115
1987 Factor SA, Dentinger MP. Early brain-stem auditory evoked responses in vertebrobasilar transient ischemic attacks. Archives of Neurology. 44: 544-7. PMID 3579667 DOI: 10.1001/archneur.1987.00520170070025  0.115
2020 Cudkowicz M, Chase MK, Coffey CS, Ecklund DJ, Thornell BJ, Lungu C, Mahoney K, Gutmann L, Shefner JM, Staley KJ, Bosch M, Foster E, Long JD, Bayman EO, Torner J, ... ... Factor SA, et al. Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials. Jama Neurology. PMID 32202612 DOI: 10.1001/Jamaneurol.2020.0367  0.114
2020 Langley J, Huddleston DE, Crosson B, Song DD, Factor SA, Hu X. Multimodal assessment of nigrosomal degeneration in Parkinson's disease. Parkinsonism & Related Disorders. 80: 102-107. PMID 32979784 DOI: 10.1016/j.parkreldis.2020.09.021  0.112
2015 Shaikh AG, Ghasia FF, DeLong MR, Jinnah HA, Freeman A, Factor SA. Ocular palatal tremor plus dystonia - new syndromic association. Movement Disorders Clinical Practice. 2: 267-270. PMID 26889496 DOI: 10.1002/mdc3.12193  0.112
2019 Weiss D, Schoellmann A, Fox MD, Bohnen NI, Factor SA, Nieuwboer A, Hallett M, Lewis SJG. Freezing of gait: understanding the complexity of an enigmatic phenomenon. Brain : a Journal of Neurology. PMID 31647540 DOI: 10.1093/Brain/Awz314  0.11
2011 Hill-Burns EM, Factor SA, Zabetian CP, Thomson G, Payami H. Evidence for more than one Parkinson's disease-associated variant within the HLA region. Plos One. 6: e27109. PMID 22096524 DOI: 10.1371/Journal.Pone.0027109  0.109
2019 Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, Bega D, LeDoux MS, Shprecher DR, Anderson KE. Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31296586 DOI: 10.1136/Jnnp-2018-319918  0.107
2014 Factor SA, Jankovic J. Editorial: Neurotherapeutics of movement disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 3-5. PMID 24366609 DOI: 10.1007/s13311-013-0241-2  0.105
2020 Lidstone SC, Nassif W, Juncos J, Factor SA, Lang AE. Diagnosing Functional Neurological Disorder: Seeing the whole picture. Cns Spectrums. 1-19. PMID 33161935 DOI: 10.1017/S1092852920001996  0.103
2016 Scorr LM, Factor SA, Jinnah H. Clinical characteristics of oromandibular dystonia: A multicenter review of 201 caseS Toxicon. 123: S75-S76. DOI: 10.1016/j.toxicon.2016.11.210  0.099
2018 Langley J, He N, Huddleston DE, Chen S, Yan F, Crosson B, Factor S, Hu X. Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30597635 DOI: 10.1002/Mds.27608  0.098
2017 Factor SA, Remington G, Comella CL, Correll CU, Burke J, Jimenez R, Liang GS, O'Brien CF. The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study. The Journal of Clinical Psychiatry. PMID 29141124 DOI: 10.4088/JCP.17m11777  0.097
2013 Khooshnoodi MA, Factor SA, Jinnah HA. Secondary blepharospasm associated with structural lesions of the brain. Journal of the Neurological Sciences. 331: 98-101. PMID 23747003 DOI: 10.1016/j.jns.2013.05.022  0.096
2012 Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1797-800. PMID 23124580 DOI: 10.1002/Mds.25237  0.095
2016 Prudente CN, Stilla R, Singh S, Buetefisch C, Evatt M, Factor SA, Freeman A, Hu XP, Hess EJ, Sathian K, Jinnah HA. A Functional Magnetic Resonance Imaging Study of Head Movements in Cervical Dystonia. Frontiers in Neurology. 7: 201. PMID 27895619 DOI: 10.3389/Fneur.2016.00201  0.095
2016 Factor SA, Hatcher-Martin JM, Morse AS, Nocera JR, Revuelta GJ. Freezing of gait that disappears: Should there be rest before rehab? Parkinsonism & Related Disorders. PMID 27103479 DOI: 10.1016/j.parkreldis.2016.04.010  0.092
2021 Jimenez-Shahed J, Barkay H, Anderson KE, Fernandez HH, Factor SA, Hauser RA, Wieman M, Gordon MF, Savola JM. Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia. Cns Spectrums. 26: 159-160. PMID 34127106 DOI: 10.1017/S1092852920002564  0.091
2020 Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Science Advances. 6. PMID 33087358 DOI: 10.1126/sciadv.aaz9360  0.089
2020 Liu C, Scorr L, Kilic-Berkmen G, Cotton A, Factor SA, Freeman A, Tran V, Liu K, Uppal K, Jones D, Jinnah HA, Sun YV. A metabolomic study of cervical dystonia. Parkinsonism & Related Disorders. 82: 98-103. PMID 33271463 DOI: 10.1016/j.parkreldis.2020.11.020  0.085
2020 Cisneros E, Stebbins GT, Chen Q, Vu JP, Benadof CN, Zhang Z, Barbano RL, Fox SH, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Adler CH, Factor SA, Reich SG, et al. It's tricky: Rating alleviating maneuvers in cervical dystonia. Journal of the Neurological Sciences. 419: 117205. PMID 33160248 DOI: 10.1016/j.jns.2020.117205  0.085
2010 Seegal RF, Marek KL, Seibyl JP, Jennings DL, Molho ES, Higgins DS, Factor SA, Fitzgerald EF, Hills EA, Korrick SA, Wolff MS, Haase RF, Todd AC, Parsons P, McCaffrey RJ. Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study. Neurobiology of Disease. 38: 219-25. PMID 20096358 DOI: 10.1016/J.Nbd.2010.01.009  0.085
2016 Jinnah HA, Factor S. The role of polymyography in the treatment of cervical dystonia: the authors reply. Journal of Neurology. PMID 27393115 DOI: 10.1007/s00415-016-8222-0  0.084
2015 Shaikh AG, Mewes K, DeLong MR, Gross RE, Triche SD, Jinnah HA, Boulis N, Willie JT, Freeman A, Alexander GE, Aia P, Butefisch CM, Esper CD, Factor SA. Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation. Parkinsonism & Related Disorders. 21: 116-9. PMID 25465373 DOI: 10.1016/J.Parkreldis.2014.11.013  0.084
2016 Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, et al. Clinimetric testing of the comprehensive cervical dystonia rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26971359 DOI: 10.1002/Mds.26534  0.083
2016 Silver MR, Hanfelt J, Factor SA. The "Shirt Collar Sign" of Cervical Dystonia. The International Journal of Neuroscience. 1-11. PMID 27245470 DOI: 10.1080/00207454.2016.1188815  0.081
1990 Factor SA. Head tremor after a remission of spasmodic torticollis Movement Disorders. 5: 353-354. PMID 2259364  0.08
2014 Factor SA, Jankovic J. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 83: 1388-9. PMID 25288700 DOI: 10.1212/01.wnl.0000455698.16732.0a  0.08
2018 Siegert S, Factor S, Liang G, Burke J. Efficacy and safety of Valbenazine (NBI-98854) in subjects with tardive dyskinesia: Results of a long-term study (KINECT 3 extension) Parkinsonism & Related Disorders. 46: e35. DOI: 10.1016/j.parkreldis.2017.11.113  0.079
2013 Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Hervé D, Sharma N, Ehrlich ME, Martemyanov KA, et al. Mutations in GNAL cause primary torsion dystonia Nature Genetics. 45: 88-92. PMID 23222958 DOI: 10.1038/Ng.2496  0.079
2019 Sharma VD, Bezchlibnyk YB, Isbaine F, Naik KB, Cheng J, Gale JT, Miocinovic S, Buetefisch C, Factor SA, Willie JT, Boulis NM, Wichmann T, DeLong MR, Gross RE. Clinical outcomes of pallidal deep brain stimulation for dystonia implanted using intraoperative MRI. Journal of Neurosurgery. 1-13. PMID 31604331 DOI: 10.3171/2019.6.Jns19548  0.076
2020 Shaikh AG, Beylergil SB, Scorr L, Kilic-Berkmen G, Freeman A, Klein C, Junker J, Loens S, Brüggemann N, Münchau A, Bäumer T, Vidailhet M, Roze E, Bonnet C, Jankovic J, ... ... Factor S, et al. Dystonia & tremor: A cross-sectional study of the dystonia coalition cohort. Neurology. PMID 33046615 DOI: 10.1212/WNL.0000000000011049  0.075
2017 Shaikh AG, Factor SA, Juncos J. Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow. Movement Disorders Clinical Practice. 4: 671-681. PMID 29333474 DOI: 10.1002/mdc3.12491  0.07
2022 Vu JP, Cisneros E, Lee HY, Le L, Chen Q, Guo XA, Rouzbehani R, Jankovic J, Factor S, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Pirio Richardson S, Stebbins GT, et al. Head tremor in cervical dystonia: Quantifying severity with computer vision. Journal of the Neurological Sciences. 434: 120154. PMID 35101766 DOI: 10.1016/j.jns.2022.120154  0.069
2009 Lungu C, Aia PG, Shih LC, Esper CD, Factor SA, Tarsy D. Tardive dyskinesia due to aripiprazole: report of 2 cases. Journal of Clinical Psychopharmacology. 29: 185-6. PMID 19512985 DOI: 10.1097/JCP.0b013e31819a4bd5  0.069
2016 Hatcher-Martin JM, Factor SA. Freezing of gait: A rare delayed complication of whole brain radiation. Parkinsonism & Related Disorders. PMID 27194005 DOI: 10.1016/j.parkreldis.2016.05.002  0.067
2008 Esper CD, Aia PG, Cloud LJ, Factor SA. Cramps and Spasms Therapeutics of Parkinson's Disease and Other Movement Disorders. 263-281. DOI: 10.1002/9780470713990.ch17  0.066
2008 Factor SA. Neuroleptic Malignant Syndrome Drug Induced Movement Disorders: Second Edition. 174-212. DOI: 10.1002/9780470753217.ch8  0.064
2012 Zutshi D, Cloud L, Factor S. Reversibility of Tardive Syndromes (P04.031) Neurology. 78: P04.031-P04.031. DOI: 10.1212/wnl.78.1_meetingabstracts.p04.031  0.064
2022 Vu JP, Cisneros E, Zhao J, Lee HY, Jankovic J, Factor SA, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Richardson SP, Stebbins GT, Elble RJ, Comella CL, Peterson DA. From null to midline: changes in head posture do not predictably change head tremor in cervical dystonia. Dystonia. 1. PMID 37101941 DOI: 10.3389/dyst.2022.10684  0.062
2021 Sun YV, Li C, Hui Q, Huang Y, Barbano R, Rodriguez R, Malaty IA, Reich S, Bambarger K, Holmes K, Jankovic J, Patel NJ, Roze E, Vidailhet M, Berman BD, ... ... Factor SA, et al. A Multi-center Genome-wide Association Study of Cervical Dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34320236 DOI: 10.1002/mds.28732  0.059
2000 Serrano-Dueñas M, Friedman JH, Factor SA. A typical antipsychotics: Clozapine-related cardiac complications (multiple letters) Movement Disorders. 15: 1300. PMID 11104235  0.053
2013 Molho ES, Factor SA. Psychosis Milestones in Drug Therapy. 24: 63-90. DOI: 10.1007/978-1-60761-429-6_5  0.051
2015 Silver MR, Factor SA. VPA, lithium, amiodarone, and other non-DA Medication-Induced Movement Disorders. 131-140. DOI: 10.1017/CBO9781107588738.013  0.048
2011 Seegal RF, Fitzgerald EF, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons P, Molho ES, Higgins DS, Factor SA, Marek KL, Seibyl JP, Jennings DL, McCaffrey RJ. Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. Journal of Exposure Science & Environmental Epidemiology. 21: 234-46. PMID 20216575 DOI: 10.1038/Jes.2010.3  0.048
2013 Seegal RF, Fitzgerald EF, McCaffrey RJ, Shrestha S, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons PJ, Molho ES, Higgins DS, Factor SA, Seibyl JP. Tibial bone lead, but not serum polychlorinated biphenyl, concentrations are associated with neurocognitive deficits in former capacitor workers. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 55: 552-62. PMID 23618890 DOI: 10.1097/Jom.0B013E318285F3Fd  0.04
2022 Bohnen NI, Costa RM, Dauer WT, Factor SA, Giladi N, Hallett M, Lewis SJG, Nieuwboer A, Nutt JG, Takakusaki K, Kang UJ, Przedborski S, Papa SM. Reply to: "Letter on Discussion of Gait Research". Movement Disorders : Official Journal of the Movement Disorder Society. 37: 1328. PMID 35707827 DOI: 10.1002/mds.29049  0.038
2018 Factor SA. Camptocormia: a consensus for grading on a curve. Parkinsonism & Related Disorders. 52: 6. PMID 29937101 DOI: 10.1016/j.parkreldis.2018.06.023  0.035
2009 Revuelta G, Gross R, Wuu J, Goyal S, Factor S, Mewes K, Triche S, Wichmann T, DeLong M, Esper C. P2.048 Screening and selection process for deep brain stimulation: the Emory experience Parkinsonism & Related Disorders. 15: S101. DOI: 10.1016/S1353-8020(09)70399-2  0.034
2013 Factor SA, Reich SG. In Memoriam: William J. Weiner, MD: June 28, 1945-December 29, 2012 Parkinsonism and Related Disorders. 19: 277-278. DOI: 10.1016/J.Parkreldis.2013.01.005  0.028
2014 Bernardini GL, Factor S, Lava N, Molho E, Ritaccio AL. Kevin Delgado Barron, MD (1929-2013) Neurology. 82: 912-913. DOI: 10.1212/WNL.0000000000000227  0.02
Hide low-probability matches.